A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules

<div>Identification of prognosis-related DEMRGs in the TCGA-LIHC dataset. (a) The Venn diagram presenting DEMRGs which were associated with OS in the univariate Cox regression analysis. (b) The heatmap showing 37 prognosis-related DEMRGs. (c) The forest plot displaying the relationship between 37 prognosis-related DEMRGs and OS in the univariate Cox regression analysis. (d) The PPI network among candidate genes obtained from the STRING database. (e) Hub genes with the top 11 degrees of interaction. (f) The correlation analysis of candidate genes.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules 

Figure 1 | A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules 